Physician profile
Scott W Mcgee
NPI 1043274525
$22,442.53
in general payments reported to CMS, 2019-2025
100 companies · $4,087 in 2025
The $4,087 reported for 2025 was more than what 79% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,222 · 2020: $1,632 · 2021: $1,994 · 2022: $3,432 · 2023: $4,351 · 2024: $3,724 · 2025: $4,087.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Education: $267.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,894.93 |
| Education | $266.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $1,629.27 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Novartis Pharmaceuticals Corporation | $1,154.16 | 2019-2025 | Piqray, Kisqali |
| Amgen INC. | $1,116.97 | 2019-2023 | Kyprolis, Lumakras, Nplate |
| Astrazeneca Pharmaceuticals LP | $973.63 | 2019-2025 | Imfinzi, Lynparza, Calquence |
| E.R. Squibb & Sons, L.L.C. | $919.58 | 2019-2025 | Opdivo, Opdualag |
| Janssen Biotech, INC. | $908.14 | 2019-2025 | Darzalex, Rybrevant, Tecvayli |
| Celgene Corporation | $889.41 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Astellas Pharma US INC | $862.96 | 2019-2025 | Xtandi, Vyloy, Xospata |
| Daiichi Sankyo INC. | $799.53 | 2019-2025 | Enhertu, Injectafer, Vanflyta |
| Eisai INC. | $774.66 | 2019-2025 | Lenvima |
| Genentech USA, INC. | $774.48 | 2019-2025 | Polivy, Venclexta, Itovebi |
| Incyte Corporation | $751.46 | 2019-2025 | Jakafi, Monjuvi, Zynyz |
| Pfizer INC. | $678.70 | 2019-2025 | |
| Abbvie INC. | $639.92 | 2019-2025 | |
| Lilly USA, LLC | $454.74 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
Show all 100 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $444.74 | 2019-2025 | |
| Pharmacyclics LLC, An Abbvie Company | $441.51 | 2019-2023 | Imbruvica, Epkinly |
| Puma Biotechnology, INC. | $407.42 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $391.41 | 2019-2025 | Fruzaqla, Alunbrig, Ninlaro |
| Genzyme Corporation | $365.18 | 2019-2025 | |
| Glaxosmithkline, LLC. | $286.00 | 2020-2025 | Ojjaara, Zejula, Jemperli |
| Ipsen Biopharmaceuticals, INC | $259.51 | 2019-2025 | Onivyde, Tazverik, Somatuline Depot |
| Seagen INC. | $256.09 | 2019-2023 | Tukysa, Padcev |
| Gilead Sciences, INC. | $241.62 | 2019-2025 | Trodelvy |
| Emd Serono, INC. | $215.04 | 2019-2025 | Tepmetko |
| Boehringer Ingelheim Pharmaceuticals, INC. | $213.40 | 2019-2024 | Gilotrif |
| Regeneron Healthcare Solutions, INC. | $212.68 | 2021-2025 | Libtayo |
| Sobi, INC | $212.66 | 2022-2025 | |
| Stemline Therapeutics INC. | $191.69 | 2022-2025 | Orserdu, Elzonris |
| Agios Pharmaceuticals, INC. | $190.34 | 2019-2025 | Pyrukynd |
| Genmab U.S., INC. | $189.56 | 2022-2025 | Epkinly, Tivdak |
| Myriad Genetic Laboratories, INC. | $183.09 | 2022-2025 | Myrisk |
| Jazz Pharmaceuticals INC. | $180.36 | 2019-2025 | |
| Amag Pharmaceuticals, INC. | $163.98 | 2019-2022 | |
| Exelixis INC. | $160.60 | 2019-2025 | Cabometyx |
| Aveo Pharmaceuticals, INC. | $160.43 | 2022-2025 | Fotivda |
| Servier Pharmaceuticals LLC | $158.69 | 2021-2025 | |
| Caris Mpi, INC. | $153.26 | 2025 | Mi Cancer Seek |
| Tesaro, INC. | $142.29 | 2019 | |
| Array Biopharma INC | $139.55 | 2020-2025 | Braftovi, Xalkori, Lorbrena |
| Beigene USA, INC. | $133.39 | 2020-2025 | Tevimbra, Brukinsa |
| Karyopharm Therapeutics INC. | $128.49 | 2021-2025 | Xpovio |
| Pharmaessentia USA Corporation | $124.07 | 2023-2025 | Besremi |
| G1 Therapeutics, INC. | $122.54 | 2021-2023 | Cosela |
| Taiho Oncology, INC. | $121.22 | 2019-2024 | |
| Pharmacosmos Therapeutics INC. | $120.97 | 2020-2025 | Monoferric, Cosela |
| Janssen Pharmaceuticals, INC | $120.56 | 2019-2022 | |
| Coherus Oncology, INC. | $116.08 | 2020-2024 | |
| Kite Pharma, INC. | $111.81 | 2021-2025 | Yescarta |
| Dova Pharmaceuticals | $100.92 | 2019-2021 | |
| Amneal Pharmaceuticals LLC | $100.82 | 2024-2025 | Avastin, Alymsys, Pemrydi Rtu |
| Alexion Pharmaceuticals, INC. | $94.32 | 2020-2024 | Ultomiris |
| Blueprint Medicines Corporation | $91.80 | 2021-2024 | Ayvakit |
| Sumitomo Pharma America, INC. | $81.38 | 2023-2025 | Orgovyx |
| Deciphera Pharmaceuticals INC. | $71.44 | 2023-2025 | Qinlock, Tgct |
| Foundation Medicine, INC. | $71.07 | 2019-2023 | |
| Adc Therapeutics America, INC. | $69.30 | 2022-2024 | |
| Tersera Therapeutics LLC | $67.26 | 2025 | Xermelo |
| Morphosys, US INC. | $64.28 | 2022-2024 | Monjuvi |
| Immunocore Limited | $61.66 | 2025 | Kimmtrak |
| Dendreon Pharmaceuticals LLC | $60.44 | 2019-2021 | |
| Rigel Pharmaceuticals, INC. | $58.02 | 2021-2023 | Tavalisse, Rezlidhia |
| Iovance Biotherapeutics, INC. | $57.62 | 2024-2025 | Amtagvi |
| Advanced Accelerator Applications | $52.88 | 2020 | |
| Sun Pharmaceutical Industries INC. | $49.74 | 2021-2025 | |
| Apellis Pharmaceuticals, INC. | $47.72 | 2022-2023 | Empaveli |
| Organon LLC | $44.97 | 2021-2024 | |
| Mirati Therapeutics, INC. | $44.85 | 2023-2024 | Krazati |
| Fennec Pharmaceuticals, INC. | $42.09 | 2025 | Fyarro |
| Legend Biotech USA INC. | $41.53 | 2024-2025 | Carvykti |
| Myovant Sciences INC. | $40.15 | 2021 | |
| Octapharma USA, INC. | $38.90 | 2025 | Octagam Immune Globulin (Human) |
| Mylan Institutional INC. | $35.71 | 2019-2020 | |
| Janssen Scientific Affairs, LLC | $35.13 | 2025 | Darzalex, Tecvayli, Talvey |
| Epizyme, INC. | $33.83 | 2021-2022 | |
| Kyowa Kirin, INC. | $32.11 | 2023 | Poteligeo |
| Clovis Oncology, INC. | $31.07 | 2019 | |
| Progenics Pharmaceuticals, INC. | $26.52 | 2022 | |
| Biocon Biologics INC | $24.93 | 2024 | Ogivri |
| Beone Medicines USA, INC. | $24.14 | 2025 | Brukinsa |
| Accord Healthcare, INC. | $23.70 | 2025 | |
| Nuvation Bio INC. | $22.35 | 2025 | Ibtrozi |
| Eusa Pharma (US) LLC | $21.58 | 2022 | |
| Tempus Ai, INC | $20.79 | 2024 | |
| Catalyst Pharmaceuticals, INC. | $20.29 | 2023 | Firdapse |
| Springworks Therapeutics, INC. | $20.24 | 2024 | Ogsiveo |
| Fresenius Kabi USA, LLC | $20.21 | 2024 | Stimufend |
| Azurity Pharmaceuticals, INC. | $19.30 | 2025 | Danziten |
| Helsinn Therapeutics (U.S.), INC. | $18.90 | 2019 | |
| Macrogenics, INC. | $18.65 | 2022 | |
| Adaptive Biotechnologies Corporation | $18.42 | 2022 | |
| Geron Corporation | $18.11 | 2025 | Rytelo |
| Secura Bio, INC. | $17.82 | 2025 | Copiktra |
| Spectrum Pharmaceuticals INC. | $16.77 | 2024 | Rolvedon |
| Syndax Pharmaceuticals, INC. | $15.13 | 2025 | |
| Immunogen, INC. | $15.12 | 2023 | Elahere |
| Novocure INC. | $14.69 | 2025 | Optune Lua (Novottf-200t) |
| Heron Therapeutics, INC. | $12.32 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $12.10 | 2019 | |
| Acceleron Pharma, INC. | $11.60 | 2021 |
Drugs and devices associated with these payments
Keytruda $830Reblozyl $369Enhertu $368Lenvima $364Jakafi $342Imbruvica $334Xtandi $330Epkinly $321Kisqali $285Lynparza $269Opdivo $230Darzalex $218Nubeqa $215Verzenio $208Jaypirca $200Imfinzi $181Vyloy $176Opdualag $175Tecvayli $172Myrisk $163Doptelet $160Rybrevant $157Orgovyx $155Monjuvi $153Mi Cancer Seek $153Venclexta $148Injectafer $147Libtayo $137Stivarga $135Piqray $130Fotivda $125Besremi $124Welireg $121Padcev $120Tukysa $120Polivy $120Talvey $115Xospata $112Fabhalta $111Ojjaara $110Carvykti $109Orserdu $108Xofigo $105Onivyde $104Retevmo $102Ibrance $101Trodelvy $95.18Keytruda Qlex $95.02Cabometyx $93.17Scemblix $90.89Talzenna $85.78Elahere $83.59Fruzaqla $81.51Ayvakit $81.12Pyrukynd $80.04Pomalyst $79.35Braftovi $73.06Zynyz $72.40Calquence $72.16Qinlock $71.44Elzonris $70.63Xpovio $70.57Cosela $67.90Xermelo $67.26Vanflyta $66.74Tivdak $66.69Monoferric $64.25Inqovi $63.68Lonsurf $63.68Alunbrig $63.41Kyprolis $62.23Kimmtrak $61.66Vitrakvi $61.55Promacta $61.47Gilotrif $61.23Adcetris $60.98Datroway $59.16Elrexfio $57.89Amtagvi $57.62Erleada $56.50Akeega $56.50Lorbrena $55.78Xalkori $55.78Zejula $54.49Jemperli $54.49Avastin $53.60Zepzelca $52.95Lumakras $47.47Pemazyre $46.56Jevtana $46.27Krazati $44.85Enjaymo $44.18Blenrep $43.71Brukinsa $43.60Balversa $43.30Wainua $42.14Fyarro $42.09Tazverik $41.80Yescarta $40.20Tepmetko $40.18
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Mcgee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.